With the analysis among 503 patents, we discovered top 59 key players by total patent application. Avanir Pharmaceuticals, Inc., Cytokine PharmaSciences, Inc., Baxalta GmbH are dominant in this area. They take 32.80% of the total patent filing.
California, United States
Patent: 73
Pennsylvania, United States
Patent: 47
ZURICH, Switzerland
Patent: 45
Illinois, United States
Patent: 39
Massachusetts, United States
Patent: 27
Illinois, United States
Patent: 25
ZURICH, Switzerland
Patent: 25
Kanagawa-ken, Japan
Patent: 20
The Board of Regents of The University of Texas System
Texas, United States
Patent: 18
With the analysis among 5 patents, we discovered top 1 start-ups by total patent application.
With the analysis among related 52 patents applied in the last 5 years. We discover 17 most active companies in this area. The fast-growing Yale University, Immunophage, MediciNova, Inc. take 42.31% of patent filing during this period.
Connecticut, United States
Patent: 12
California, United States
Patent: 5
Utah, United States
Patent: 4
Massachusetts, United States
Patent: 2
New Mexico, United States
Patent: 2
Jiangsu Sheng, China
Patent: 1
With the analysis among related 52 patents in last 5 years, we discover 9 new entrants. Immunophage, MediciNova, Inc., Yeda Research & Development Co. Ltd. are the most active new entrants in this area.
California, United States
Patent: 5
New Mexico, United States
Patent: 2
Jiangsu Sheng, China
Patent: 1
undefined undefined
Patent: 1
Taiwan Province, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
With the analysis among 194 patents, we discovered top 17 universities and scientific research institutions by total patent application. Yale University, University of South Florida, The Johns Hopkins University are dominant in this area. They take 39.18% of the total patent filing.
Connecticut, United States
Patent: 29
Chiba-ken, Japan
Patent: 7
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 3
New Mexico, United States
Patent: 2
Tokushima-ken, Japan
Patent: 2
Connecticut, United States
Patent: 1